David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
With investors clamoring for dividend stocks, companies have responded by instituting large hikes in their payouts, which has led to the doubly good fortune of rising income streams and rising share… Read More
Everyone loves a good turnaround story. This is especially true for investors when it comes to turnaround stocks. These often-scorned investments can prove a host of doubters wrong and deliver stunning… Read More
This is not a good time to be running a tech company. Major corporate clients continue to withhold capital spending funds, investing only in areas that promise rapid paybacks or can… Read More
At first blush, it’s hard to reconcile a pair of percentages: 2% and 22%. The first figure is roughly the speed at which the U.S. economy has been growing. The second figure is the speed at which dividend… Read More
Here at StreetAuthority, we spend a great deal of time focusing on dividend-paying stocks. Rising dividend payments have become the hallmark of the modern investing era as companies begin to return… Read More
We’re just a few weeks away from the one-year anniversary of the much-hyped initial public offering (IPO) for Facebook (Nasdaq: FB). The social media giant had developed so quickly while it was still a private company… Read More
In the past 30 years, hundreds of thousands of people have been given a second chance after battling cancer. Many of these cancer survivors have long been in remission, but there’s still reason for concern. Cancer kills more than 500,000 Americans every… Read More
I recently heard from an old friend. He told me of his battle with colon cancer. His doctors had given him a 30% chance of surviving, but thanks a new generation of powerful anti-cancer drugs, his cancer has been in remission for nearly five years now. You probably know someone… Read More
As we head toward Memorial Day weekend, summer travel plans are being discussed around many kitchen tables. Americans are hitting the road again, packing hotels in major cities as some national parks brace for a record number of visitors. Many conversations in foreign languages… Read More
There isn’t a lot of good economic news to go around these days. In the final year of President George W. Bush’s second term and in the first two years of President Barack Obama’s first term, the… Read More
